Phase 1 data demonstrate activation of tumor-selective interferon signaling in patients with advanced melanoma - - Data supportive of CX-801’s mechanism of action and the ongoing Phase 1 combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback